Potential value of pharmacological protocols in trauma

Current Opinion in Anaesthesiology

Volumn 26, Issue 2, 2013, Pages 221-229

  Schöchl, Herbert ^a,b   Schlimp, Christoph J ^b   Voelckel, Wolfgang ^a  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

Author keywords

coagulation factor concentrate; massive blood loss; point of care testing; tranexamic acid; trauma induced coagulopathy

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 13; FIBRINOGEN; PROTHROMBIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

ANTICOAGULANT THERAPY; BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; CLINICAL PROTOCOL; CRYOPRECIPITATION; EARLY INTERVENTION; ERYTHROCYTE; FIBRINOLYSIS; HUMAN; INJURY; PRIORITY JOURNAL; PROTHROMBIN TIME; REVIEW; SURVIVAL; THAWING; THROMBOCYTE TRANSFUSION; TREATMENT OUTCOME;

BLOOD COAGULATION DISORDERS; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; FIBRINOGEN; HEMOSTATICS; HUMANS; POINT-OF-CARE SYSTEMS; THROMBELASTOGRAPHY; TRANEXAMIC ACID; WOUNDS AND INJURIES;

EID: 84874949918     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: 10.1097/ACO.0b013e32835cca92     Document Type: Review

References (103)

1. Brohi K, Cohen MJ, Davenport RA. Acute coagulopathy of trauma: mechanism, identification and effect. Curr Opin Crit Care 2007; 13:680-685.
2. Maegele M, Lefering R, Paffrath T, et al. Red-blood-cell to plasma ratios transfused during massive transfusion are associated with mortality in severe multiple injury: a retrospective analysis from the Trauma Registry of the Deutsche Gesellschaft fur Unfallchirurgie. Vox Sang 2008; 95:112-119.
3. MacLeod JB, Lynn M, McKenney MG, et al. Early coagulopathy predicts mortality in trauma. J Trauma 2003; 55:39-44.
4. Johansson PI. Coagulation monitoring of the bleeding traumatized patient. Curr Opin Anaesthesiol 2012; 25:235-241.
5. Holcomb JB, Minei KM, Scerbo ML, et al. Admission rapid thrombelastography can replace conventional coagulation tests in the emergency department: experience with 1974 consecutive trauma patients. Ann Surg 2012; 256:476-486.
6. Schö chl H, Maegele M, Solomon C, et al. Early and individualized goaldirected therapy for trauma-induced coagulopathy. Scand J Trauma Resusc Emerg Med 2012; 20:15.
7. Borgman MA, Spinella PC, Perkins JG, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007; 63:805-813.
8. Cotton BA, Au BK, Nunez TC, et al. Predefined massive transfusion protocols are associated with a reduction in organ failure and postinjury complications. J Trauma 2009; 66:41-48; discussion 8-9.
9. Peiniger S, Nienaber U, Lefering R, et al. Balanced massive transfusion ratios in multiple injury patients with traumatic brain injury. Crit Care 2011; 15:R68.
10. Zink KA, Sambasivan CN, Holcomb JB, et al. A high ratio of plasma and platelets to packed red blood cells in the first 6 h of massive transfusion improves outcomes in a large multicenter study. Am J Surg 2009; 197:565-570; discussion 70.
11. Cotton BA, Gunter OL, Isbell J, et al. Damage control hematology: the impact of a trauma exsanguination protocol on survival and blood product utilization. J Trauma 2008; 64:1177-1182; discussion 82-83.
12. Gunter OL Jr, Au BK, Isbell JM, et al. Optimizing outcomes in damage control resuscitation: identifying blood product ratios associated with improved survival. J Trauma 2008; 65:527-534.
13. Holcomb JB, Zarzabal LA, Michalek JE, et al. Increased platelet :RBC ratios are associated with improved survival after massive transfusion. J Trauma 2011; 71:S318-S328.
14. Stansbury LG, Dutton RP, Stein DM, et al. Controversy in trauma resuscitation: do ratios of plasma to red blood cells matter? Transfus Med Rev 2009; 23:255-265.
15. Ho AM, Dion PW, Yeung JH, et al. Prevalence of survivor bias in observational studies on fresh frozen plasma : erythrocyte ratios in trauma requiring massive transfusion. Anesthesiology 2012; 116:716-728.
16. Mitra B, Mori A, Cameron PA, et al. Fresh frozen plasma (FFP) use during massive blood transfusion in trauma resuscitation. Injury 2010; 41:35-39.
17. Davenport R, Curry N, Manson J, et al. Hemostatic effects of fresh frozen plasma may be maximal at red cell ratios of 1 : 2. J Trauma 2011; 70:90-95; discussion 5-6.
18. Kashuk JL, Moore EE, Johnson JL, et al. Postinjury life threatening coagulopathy: is 1 : 1 fresh frozen plasma : packed red blood cells the answer? J Trauma 2008; 65:261-270; discussion 70-71.
19. Scalea TM, Bochicchio KM, Lumpkins K, et al. Early aggressive use of fresh frozen plasma does not improve outcome in critically injured trauma patients. Ann Surg 2008; 248:578-584.
20. De Biasi AR, Stansbury LG, Dutton RP, et al. Blood product use in trauma resuscitation: plasma deficit versus plasma ratio as predictors of mortality in trauma (CME). Transfusion 2011; 51:1925-1932.
21. Sambasivan CN, Kunio NR, Nair PV, et al. High ratios of plasma and platelets to packed red blood cells do not affect mortality in nonmassively transfused patients. J Trauma 2011; 71:S329-S336.
22. Murad MH, Stubbs JR, Gandhi MJ, et al. The effect of plasma transfusion on morbidity and mortality: a systematic review and meta-analysis. Transfusion 2010; 50:1370-1383.
23. Allen SR, Kashuk JL. Unanswered questions in the use of blood component therapy in trauma. Scand J Trauma Resusc Emerg Med 2011; 19:5.
24. Zehtabchi S, Nishijima DK. Impact of transfusion of fresh-frozen plasma and packed red blood cells in a 1 : 1 ratio on survival of emergency department patients with severe trauma. Acad Emerg Med 2009; 16:371-378.
25. Sorensen B, Fries D. Emerging treatment strategies for trauma-induced coagulopathy. Br J Surg 2012; 99 (Suppl. 1):40-50.
26. Riskin DJ, Tsai TC, Riskin L, et al. Massive transfusion protocols: the role of aggressive resuscitation versus product ratio in mortality reduction. J Am Coll Surg 2009; 209:198-205.
27. Johansson PI, Stensballe J, Ostrowski SR. Current management of massive hemorrhage in trauma. Scand J Trauma Resusc Emerg Med 2012; 20:47.
28. Dirks J, Jorgensen H, Jensen CH, et al. Blood product ratio in acute traumatic coagulopathy-effect on mortality in a Scandinavian level 1 trauma centre. Scand J Trauma Resusc Emerg Med 2010; 18:65.
29. Shuja F, Shults C, Duggan M, et al. Development and testing of freeze-dried plasma for the treatment of trauma-associated coagulopathy. J Trauma 2008; 65:975-985.
30. Daban JL, Clapson P, Ausset S, et al. Freeze dried plasma: a French army specialty. Crit Care 2010; 14:412.
31. Dara SI, Rana R, Afessa B, et al. Fresh frozen plasma transfusion in critically ill medical patients with coagulopathy. Crit Care Med 2005; 33:2667-2671.
32. Sarani B, Dunkman WJ, Dean L, et al. Transfusion of fresh frozen plasma in critically ill surgical patients is associated with an increased risk of infection. Crit Care Med 2008; 36:1114-1118.
33. Watson GA, Sperry JL, Rosengart MR, et al. Fresh frozen plasma is independently associated with a higher risk of multiple organ failure and acute respiratory distress syndrome. J Trauma 2009; 67:221-227; discussion 8-30.
34. Sperry JL, Ochoa JB, Gunn SR, et al. An FFP :PRBC transfusion ratio1:1.5 is associated with a lower risk of mortality after massive transfusion. J Trauma 2008; 65:986-993.
35. Chaiwat O, Lang JD, Vavilala MS, et al. Early packed red blood cell transfusion and acute respiratory distress syndrome after trauma. Anesthesiology 2009; 110:351-360.
36. Schö chl H, Nienaber U, Hofer G, et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010; 14:R55.
37. Grassetto A, De Nardin M, Ganzerla B, et al. ROTEM(R)-guided coagulation factor concentrate therapy in trauma: 2-year experience in Venice, Italy. Crit Care 2012; 16:428.
38. Ziegler B, Schimke C, Marchet P, et al. Severe pediatric blunt trauma: successful ROTEM-guided hemostatic therapy with fibrinogen concentrate and no administration of fresh frozen plasma or platelets. Clin Appl Thromb Hemost 2012. [Epub ahead of print].
39. Johansson PI, Stissing T, Bochsen L, Ostrowski SR. Thrombelastography and tromboelastometry in assessing coagulopathy in trauma. Scand J Trauma Resusc Emerg Med 2009; 17:45.
40. Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005; 27:81-90.
41. Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 2008; 106:1366-1375.
42. Kashuk JL, Moore EE, Sawyer M, et al. Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma. Ann Surg 2010; 252:434-442; discussion 43-44.
43. Schö chl H, Frietsch T, Pavelka M, Jambor C. Hyperfibrinolysis after major trauma: differential diagnosis of lysis patterns and prognostic value of thrombelastometry. J Trauma 2009; 67:125-131.
44. Theusinger OM, Wanner GA, Emmert MY, et al. Hyperfibrinolysis diagnosed by rotational thromboelastometry (ROTEM) is associated with higher mortality in patients with severe trauma. Anesth Analg 2011; 113:1003-1012.
45. Schö chl H, Voelckel W, Maegele M, Solomon C. Trauma-associated hyperfibrinolysis. Hamostaseologie 2012; 32:22-27.
46. Cotton BA, Harvin JA, Kostousouv V, et al. Hyperfibrinolysis at admission is an uncommon but highly lethal event associated with shock and prehospital fluid administration. J Trauma Acute Care Surg 2012; 73:365-370.
47. Ives C, Inaba K, Branco BC, et al. Hyperfibrinolysis elicited via thromboelastgraphy predicts mortality in trauma. J Am Coll Surg 2012; 215:496-502.
48. Levrat A, Gros A, Rugeri L, et al. Evaluation of rotation thrombelastgraphy for the diagnosis of hyperfibrinolysis in trauma patients. Br J Anaesth 2008; 100:792-797.
49. Carroll RC, Craft RM, Langdon RJ, et al. Early evaluation of acute traumatic coagulopathy by thrombelastography. Transl Res 2009; 154:34-39.
50. Johansson PI. Goal-directed hemostatic resuscitation for massively bleeding patients: the Copenhagen concept. Transfus Apher Sci 2010; 43:401-405.
51. Theusinger OM, Madjdpour C, Spahn DR. Resuscitation and transfusion management in trauma patients: emerging concepts. Curr Opin Crit Care 2012; 18:661-670.
52. Gonzalez EA, Moore FA, Holcomb JB, et al. Fresh frozen plasma should be given earlier to patients requiring massive transfusion. J Trauma 2007; 62:112-119.
53. Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma 2003; 54:1127-1130.
54. Davenport R, Manson J, De'Ath H, et al. Functional definition and characterization of acute traumatic coagulopathy. Crit Care Med 2011; 39:2652-2658.
55. Toulon P, Ozier Y, Ankri A, et al. Point-of-care versus central laboratory coagulation testing during haemorrhagic surgery. A multicenter study. Thromb Haemost 2009; 101:394-401.
56. Cotton BA, Faz G, Hatch QM, et al. Rapid thrombelastography delivers realtime results that predict transfusion within 1 h of admission. J Trauma 2011; 71:407-414; discussion 14-17.
57. Kashuk JL, Moore EE, Le T, et al. Noncitrated whole blood is optimal for evaluation of postinjury coagulopathy with point-of-care rapid thrombelastography. J Surg Res 2009; 156:133-138.
58. Woolley T, Midwinter M, Spencer P, et al. Utility of interim ROTEM1 values of clot strength, A5 and A10, in predicting final assessment of coagulation status in severely injured battle patients. Injury 2012. http://dx.doi.org/10.1016/j.injury.2012.03.018
59. Doran CM, Woolley T, Midwinter MJ. Feasibility of using rotational thromboelastometry to assess coagulation status of combat casualties in a deployed setting. J Trauma 2010; 69 (Suppl. 1):S40-S48.
60. Lang T, Bauters A, Braun SL, et al. Multicentre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagul Fibrinolysis 2005; 16:301-310.
61. Genet GF, Ostrowski SR, Sorensen AM, Johansson PI. Detection of tPAinduced hyperfibrinolysis in whole blood by RapidTEG, KaolinTEG, and functional FibrinogenTEG in healthy individuals. Clin Appl Thromb Hemost 2012; 18:638-644.
62. Jeger V, Willi S, Liu T, et al. The rapid TEG alpha-angle may be a sensitive predictor of transfusion in moderately injured blunt trauma patients. Sci World J 2012; 2012:821794.
63. Kheirabadi BS, Crissey JM, Deguzman R, Holcomb JB. In vivo bleeding time and in vitro thrombelastography measurements are better indicators of dilutional hypothermic coagulopathy than prothrombin time. J Trauma 2007; 62:1352-1359; discussion 9-61.
64. Nystrup KB, Windelov NA, Thomsen AB, Johansson PI. Reduced clot strength upon admission, evaluated by thrombelastography (TEG), in trauma patients is independently associated with increased 30-day mortality. Scand J Trauma Resusc Emerg Med 2011; 19:52.
65. Pezold M, Moore EE, Wohlauer M, et al. Viscoelastic clot strength predicts coagulation-related mortality within 15 min. Surgery 2012; 151:48-54.
66. Schö chl H, Cotton B, Inaba K, et al. FIBTEM provides early prediction of massive transfusion in trauma. Crit Care 2011; 15:R265.
67. Leemann H, Lustenberger T, Talving P, et al. The role of rotation thromboelastometry in early prediction of massive transfusion. J Trauma 2010; 69:1403-1408; discussion 8-9.
68. Gö rlinger K, Fries D, Dirkmann D, et al. Reduction of fresh frozen plasma requirements by perioperative point-of-care coagulation management with early calculated goal-directed therapy. Transfus Med Hemother 2012; 39:104-113.
69. Plotkin AJ, Wade CE, Jenkins DH, et al. A reduction in clot formation rate and strength assessed by thrombelastography is indicative of transfusion requirements in patients with penetrating injuries. J Trauma 2008; 64:S64-S68.
70. Schö chl H, Schlimp CJ. Trauma bleeding management: the concept of goaldirected primary care. Anesth Analg (in press).
71. Fries D, Innerhofer P, Schobersberger W. Time for changing coagulation management in trauma-related massive bleeding. Curr Opin Anaesthesiol 2009; 22:267-274.
72. Korte WF. XIII in perioperative coagulation management. Best Pract Res Clin Anaesthesiol 2010; 24:85-93.
73. Fenger-Eriksen C, Jensen TM, Kristensen BS, et al. Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebocontrolled clinical trial. J Thromb Haemost 2009; 7:795-802.
74. Rahe-Meyer N, Sorensen B. For: Fibrinogen concentrate for management of bleeding. J Thromb Haemost 2011; 9:1-5.
75. Haas T, Fries D, Velik-Salchner C, et al. Fibrinogen in craniosynostosis surgery. Anesth Analg 2008; 106:725-731; table of contents.
76. Levy JH, Szlam F, Tanaka KA, Sniecienski RM. Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding. Anesth Analg 2012; 114:261-274.
77. Schö chl H, Solomon C, Traintinger S, et al. Thromboelastometric (ROTEM) findings in patients suffering from isolated severe traumatic brain injury. J Neurotrauma 2011; 28:2033-2041.
78. Chambers LA, Chow SJ, Shaffer LE. Frequency and characteristics of coagulopathy in trauma patients treated with a low-or high-plasma-content massive transfusion protocol. Am J Clin Pathol 2011; 136:364-370.
79. Rourke C, Curry N, Khan S, et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost 2012; 10:1342-1351.
80. Rossaint R, Bouillon B, Cerny V, et al. Management of bleeding following major trauma: an updated European guideline. Crit Care 2010; 14:R52.
81. Meyer MA, Ostrowski SR, Windelov NA, Johansson PI. Fibrinogen concentrates for bleeding trauma patients: what is the evidence? Vox Sang 2011; 101:185-190.
82. Stinger HK, Spinella PC, Perkins JG, et al. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma 2008; 64:S79-S85; discussion S85.
83. O'Shaughnessy DF, Atterbury C, Bolton Maggs P, et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004; 126:11-28.
84. Theusinger OM, Baulig W, Seifert B, et al. Relative concentrations of haemostatic factors and cytokines in solvent/detergent-treated and freshfrozen plasma. Br J Anaesth 2011; 106:505-511.
85. Chowdary P, Saayman AG, Paulus U, et al. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 2004; 125:69-73.
86. Nascimento B, Rizoli S, Rubenfeld G, et al. Cryoprecipitate transfusion: assessing appropriateness and dosing in trauma. Transfus Med 2011; 21:394-401.
87. Sorensen B, Bevan D. A critical evaluation of cryoprecipitate for replacement of fibrinogen. Br J Haematol 2010; 149:834-843.
88. Fenger-Eriksen C, Ingerslev J, Sorensen B. Fibrinogen concentrate-a potential universal hemostatic agent. Expert Opin Biol Ther 2009; 9:1325-1333.
89. Solomon C, Pichlmaier U, Schoechl H, et al. Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery. Br J Anaesth 2010; 104:555-562.
90. Okamoto S, Hijikata-Okunomiya A, Wanaka K, et al. Enzyme-controlling medicines: introduction. Semin Thromb Hemost 1997; 23:493-501.
91. Shakur H, Roberts I, Bautista R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010; 376:23-32.
92. Roberts I, Shakur H, Afolabi A, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011; 377:1096-1101; 101.e1-101.e2.
93. Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ. Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) study. Arch Surg 2012; 147:113-119.
94. Dunbar NM, Chandler WL. Thrombin generation in trauma patients. Transfusion 2009; 49:2652-2660.
95. Schreiber MA, Differding J, Thorborg P, et al. Hypercoagulability is most prevalent early after injury and in female patients. J Trauma 2005; 58:475-480; discussion 80-81.
96. Boffard KD, Riou B, Warren B, et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 2005; 59:8-15; discussion 8-15.
97. Hauser CJ, Boffard K, Dutton R, et al. Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage. J Trauma 2010; 69:489-500.
98. Schö chl H, Forster L, Woidke R, et al. Use of rotation thromboelastometry (ROTEM) to achieve successful treatment of polytrauma with fibrinogen concentrate and prothrombin complex concentrate. Anaesthesia 2010; 65:199-203.
99. Schochl H, Nienaber U, Maegele M, et al. Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care 2011; 15:R83.
100. Joseph B, Amini A, Friese RS, et al. Factor IX complex for the correction of traumatic coagulopathy. J Trauma Acute Care Surg 2012; 72:828-834.
101. Sørensen B, Spahn DR, Innerhofer P, et al. Prothrombin complex concentrates: evaluation of safety and thrombogenicity. Crit Care 2010; 15:201.
102. Johnson JL, Moore EE, Kashuk JL, et al. Effect of blood products transfusion on the development of postinjury multiple organ failure. Arch Surg 2010; 145:973-977.
103. Holness L, Knippen MA, Simmons L, Lachenbruch PA. Fatalities caused by TRALI. Transfus Med Rev 2004; 18:184-188.